SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-134976
Filing Date
2016-11-16
Accepted
2016-11-16 16:39:31
Documents
1
Period of Report
2016-11-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v453239_3.html 3  
1 OWNERSHIP DOCUMENT v453239_3.xml 3 2999
  Complete submission text file 0001144204-16-134976.txt   4773
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Patlis Alla (Reporting) CIK: 0001639227 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 162002840